Monsanto Buys Some Assets of Agradis from Synthetic Genomics, Plenus | GenomeWeb

NEW YORK (GenomeWeb News) – Monsanto today announced it has acquired some of the assets of genomics-based plant breeding firm Agradis, a little more than one year after the company was formed by J. Craig Venter's Synthetic Genomics and Mexican investment and management firm Plenus.

Included in the assets purchased by Monsanto are the Agradis name, its collection of microbes for improving crop productivity, and Agradis' R&D site in La Jolla, Calif.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.